CYP2A6 and lung cancer: In addition, it is reported that the plasma concentration of cotinine, a major metabolite of nicotine, is considerably higher in carriers of wild-type alleles of CYP2A6 than that in carriers of null or reduced-function alleles of CYP2A6, raising the possibility that cotinine plays an important role in the development of lung cancer [25].